Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/7/2019
SIETES contiene 92793 citas

 
 
 1 a 20 de 21 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Jayadevappa R, Chhatre S, Malcowikz B, Parikh RB, Guzzo T, Wein AJ. Association between androgen deprivation therapy use and diagnosis of dementia in men with prostate cancer. JAMA Network Open 2019;2:e196562. [Ref.ID 103156]
2. Cita con resumen
D'Amico AV, Chen M-H, Renshaw A, Loffredo M, Kantoff PW. Long-term follow-up of a randomized trial of radiation with or without androgen deprivation therapy for localized prostate cancer. JAMA 2015;314:1291-3. [Ref.ID 99525]
3. Cita con resumen
Lapi F, Azoulay L, Niazi MT, Yin H, Benayoun S, Suissa S. Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA 2013;310:289-96. [Ref.ID 95834]
4. Cita con resumen
Hyde R. Germany launches investigation into human trials scandal. Lancet 2013;382:115-6. [Ref.ID 95826]
6.Tiene citas relacionadas Cita con resumen
Nguyen PL, Je Y, Schutz FAB, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trial. JAMA 2011;306:2359-66. [Ref.ID 91924]
7.Tiene citas relacionadas
Kelly WK, Gomella LG. Androgen deprivation therapy and competing risks. JAMA 2011;306:2382-3. [Ref.ID 91670]
9.Tiene citas relacionadas Cita con resumen
Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, Giordano M, Garrone O, Pronzato P, Bighin C, Levaggi A, Giraudi S, Cresti N, Magnolfi E, Scotto T, Vecchio C, Venturini M. Effect of gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 2011;306:269-76. [Ref.ID 90932]
10. Cita con resumen
Anónimo. Diénogest. Endométriose: toujours pas de progrès. Prescrire 2011;31:495. [Ref.ID 90881]
11. Cita con resumen
Anónimo. Agonistes de la GnRH: diabètes et troubles cardiaques. Prescrire 2011;31:272. [Ref.ID 90395]
13. Cita con resumen
Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-99. [Ref.ID 71902]
14.
Anónimo. Ganirélix. Voisin du cétrorélix pour la simulation ovarienne. Prescrire 2001;21:736. [Ref.ID 59742]
15.Tiene citas relacionadas
Vaughn DJ. Hormonal therapy for advanced prostate cancer. Ann Intern Med 2000;132:584-5. [Ref.ID 50278]
16.Tiene citas relacionadas Cita con resumen
Seidenfeld J, Samson DJ, Hasselblad V, Aronson N, Albertsen PC, Bennett CL, Wilt TJ. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med 2000;132:566-77. [Ref.ID 50276]
17.
Bergqvist A. Current drug therapy recommendations for the treatment of endometriosis. Drugs 1999;58:39-50. [Ref.ID 45223]
18. Cita con resumen
Anónimo. Managing endometriosis. Drug Ther Bull 1999;37:25-9. [Ref.ID 43957]
19. Cita con resumen
Moffat LEF. Therapeutic choices in prostate cancer. Prescr J 1999;39:16-23. [Ref.ID 43175]
20. Cita con resumen
Anónimo. Buséréline. Prescrire 1994;14:533-4. [Ref.ID 22120]
Seleccionar todas
 
 1 a 20 de 21 siguiente >>